ArticleBMC infectious diseases2025
CCDC122-LACC1 gene polymorphism is associated with protection against leprosy in a population from Northeastern Brazil: a case-control study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A review of bloodstream infections-pathogens, pathogenesis, diagnostic strategies, treatment methods-challenges and future aspects.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
introductionLeprosy is a disease caused by Mycobacterium leprae and Mycobacterium lepromatosis, affecting the skin and peripheral nerves. In 2022, Brazil registered more than 19,000 new cases, considered a public health problem in the country. Interactions between the pathogen, host genetics, and the environment are factors to be considered for the development of leprosy. The CCDC122-LACC1 and IL23R genes play important roles in immune regulation. To understand the genetic basis of leprosy, this study aimed to investigate the association of SNPs belonging to the CCDC122-LACC1 and IL23R genes with leprosy in a population from northeastern Brazil.
methodsA case-control study was conducted, using confirmed leprosy patients (cases) and individuals health donors (controls). Subjects were recruited from Northeastern states of Brazil, with a total sample size 952 (562 in Alagoas and 390 in Bahia and Pernambuco, being 488 samples from cases (298 in Alagoas and 190 in Bahia and Pernambuco) and 464 controls (264 in Alagoas and 200 in Bahia and Pernambuco). Genotyping of the SNPs CCDC122-LACC1 and IL23R was performed using real-time PCR (Taqman, StepOne Plus™). Associations were quantified using odds ratios with 95% confidence intervals, and were performed in the R environment (v.3.4.4).
resultsThe results demonstrated that SNP CDC122-LACC1 was associated with protection against leprosy in the population of Alagoas (ORCC = 0.58, p = 0.02), and in the combined analysis of the populations of Northeastern Brazil (ORCC = 0.65, p = 0.02), which was also associated with the multibacillary operational classification in the populations mentioned above. While analyzing the IL23R polymorphism, no association with leprosy was observed in any of the analyses performed in the study populations, and no association was identified with the operational classifications of the disease.
conclusionsThe SNP rs4942254 in the CCDC122-LACC1 gene was associated with protection against development of leprosy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.